학술논문
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer Disease
Document Type
Article
Author
Source
In Clinical Therapeutics November 2022 44(11):1449-1462
Subject
Language
ISSN
0149-2918